Literature DB >> 8747836

Mitochondria, magnesium and migraine.

K M Welch1, N M Ramadan.   

Abstract

The evidence for disordered mitochondrial oxidative phosphorylation and reduced intracellular free magnesium in brain and body tissue of migraine suffers both between and during an attack is reviewed. We propose that between attacks these metabolic shifts cause instability of neuronal function which enhances the susceptibility of brain to develop a migraine attack.

Entities:  

Mesh:

Year:  1995        PMID: 8747836     DOI: 10.1016/0022-510x(95)00196-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

Review 1.  Acute and prophylactic treatments for migraine: present and future.

Authors:  Alan M Rapoport
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

2.  Therapy of Migraine Headache in Cancer Patients.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 3.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

4.  Disease duration of episodic migraine correlates with modified amplitudes and habituation of contingent negative variation.

Authors:  Peter Kropp; Thomas-Martin Wallasch; Britta Müller; Bianca Meyer; Stephanie Darabaneanu; Christoph Bosse; Armin Keller; Wolfgang Meyer; Wolf-Dieter Gerber
Journal:  J Neural Transm (Vienna)       Date:  2014-11-29       Impact factor: 3.575

Review 5.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 6.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

7.  Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group.

Authors:  Ravi Gupta; Rahul Pathak; Manjeet Singh Bhatia; Basu Deb Banerjee
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

Review 8.  Complementary and alternative treatments for childhood headaches.

Authors:  Stewart J Tepper
Journal:  Curr Pain Headache Rep       Date:  2008-10

9.  Prevalence and risk of migraine headaches in adult fragile X premutation carriers.

Authors:  J Au; R S Akins; L Berkowitz-Sutherland; H-T Tang; Y Chen; A Boyd; F Tassone; D V Nguyen; R Hagerman
Journal:  Clin Genet       Date:  2013-02-21       Impact factor: 4.438

10.  Screening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean Migraineurs.

Authors:  Lami Kang; Soon-Tae Lee; Wooseok Im; Seung Chan Kim; Kim Sung Hun; Byung-Kun Kim; Manho Kim
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.